Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 91 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
901 12.4 months Advanced hepatocellular carcinoma 4 Chemotherapy
National Cancer Center Hospital Japan 4/2008
Treatment Details: Patients: This phase II study involved 20 men with advanced hepatocellular carcinoma (liver cancer). The median age was 66, ranging from 37 to 81 years of age. Treatment: Patients were
 
902 12.4 months Malignant pleural mesothelioma Surgery
Medical University of Vienna Austria 4/2008
Treatment Details: Patients: This study involved forty-nine patients with malignant pleural mesothelioma. There were 10 women and 39 men, with a median age of 59 years, ranging from 28 to 81. Some had previ
 
903 12.4 months Metastatic hormone-refractory prostate cancer 4 Chemotherapy
Dana-Farber Cancer Institute United States 2/2008
Treatment Details: Patients: This phase II study involved 34 men with metastatic hormone-refractory (not responding to this type of treatment) prostate cancer. These patients were also refractory to docetaxe
 
904 12.4 months Metastatic melanoma 4 Immunotherapy
Sunnybrook Health Sciences Centre Canada 9/2012
Treatment Details: Patients: This phase 2 study involved 40 metastatic melanoma patients who were not previously treated. The median patient age was 56 years and 24 patients were male. Treatment: Patient
 
905 12.4 months Metastatic melanoma 4 Chemotherapy
University of Pittsburgh Cancer Institute United States 11/2012
Treatment Details: Patients: This phase 2 study involved 39 metastatic melanoma patients. The median patient age was 63.3 years and 69% were male. Treatment: Patients were treated with the chemotherapy a
 
906 12.4 months Advanced urothelial cancer 4 Chemotherapy
Kitasato University School of Medicine Japan 10/2011
Treatment Details: Patients: This study involved 24 patients with advanced urothelial carcinoma who had previously been treated with methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy. The med
 
907 12.4 months Hepatocellular carcinoma 5 Biologic therapy
Herbert Irving Comprehensive Cancer Center United States 6/2008
Treatment Details: Patients: This phase II study involved 46 patients with hepatocellular carcinoma with a median age of 58 years; 83% were male. Treatment: Patients were treated with the biologic therapy
 
908 12.4 months Metastatic melanoma 4 Immunotherapy
Human Immune Therapy Center, University of Virginia United States 8/2013
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into four separate treatment groups. Group A had 47 patients with a median age of 65 years; 56.1% were m
 
909 12.4 months Metastatic colorecal cancer 5 Biologic therapy
Chemotherapy
Rocky Mountain Cancer Center United States 3/2013
Treatment Details: Patients: This phase 2 study involved patients with previously treated metastatic colorectal cancer with the KRAS mutation. These patients were divided into three separate treatment groups.
 
910 12.4 months Recurrent ovarian cancer 4 Biologic therapy
Chemotherapy
H. Lee Moffitt Cancer Center and Research Institute United States 4/2013
Treatment Details: Patients: This phase 2 study involved 41 recurrent ovarian cancer patients who had prior platinum-based chemotherapy. The average patient age was 58.2 years. Treatment: Patients were t
 
Page 91 of 187  | Previous Page  | Next Page